Oncology Partnerships EVERSANA demonstrates strong oncology commercialization capabilities, evidenced by active involvement in major oncology events and multiple oncology focused client engagements. This positions you to partner on go-to-market, pricing and payer strategies for cancer therapies, particularly in immunotherapies and targeted treatments.

Payer Access Transformation The acquisition of Waltz Health signals a strategic push to disrupt traditional PBMs and improve drug access for employers and payers. A joint offering around pricing optimization, payer negotiations, and direct-to-employer procurement could expand market reach for new launches.

AI Powered Growth EVERSANA's AI recognition and data-driven capabilities suggest strong potential for analytics in market access, pricing optimization, and patient support personalization. Propose pilots of AI-enabled analytics to accelerate launch readiness and optimize reimbursement strategies.

Global Biotech Launchpad Serving startups to established pharma with end-to-end commercialization across pricing, market access, marketing, patient support, and distribution creates a scalable platform for early-stage biotech clients seeking U.S. launches and international expansion.

Digital Launch Ops The tech stack indicates emphasis on digital marketing, marketing operations, and launch execution. Offer services to integrate digital campaigns, marketing operations automation, and patient engagement programs to accelerate time-to-market and optimize channel distribution.